A detailed history of Deka Bank Deutsche Girozentrale transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 217,700 shares of FOLD stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
217,700
Previous 217,700 -0.0%
Holding current value
$2.15 Million
Previous $2.14 Million 7.54%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

BUY
$6.23 - $11.12 $747,600 - $1.33 Million
120,000 Added 122.82%
217,700 $2.3 Million
Q1 2022

Apr 28, 2022

BUY
$7.89 - $12.48 $70,221 - $111,072
8,900 Added 10.02%
97,700 $939,000
Q4 2021

Feb 02, 2022

BUY
$9.82 - $12.44 $24,550 - $31,100
2,500 Added 2.9%
88,800 $1.06 Million
Q4 2020

Mar 12, 2021

SELL
$13.47 - $24.89 $1 Million - $1.85 Million
-74,300 Reduced 46.26%
86,300 $1.94 Million
Q3 2020

Oct 29, 2020

BUY
$12.89 - $15.89 $2.07 Million - $2.55 Million
160,600 New
160,600 $2.22 Million
Q4 2019

Feb 04, 2020

SELL
$7.48 - $10.75 $887,128 - $1.27 Million
-118,600 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$8.02 - $13.25 $1.01 Million - $1.67 Million
-126,000 Reduced 51.51%
118,600 $957,000
Q2 2019

Aug 01, 2019

BUY
$10.96 - $14.4 $1.95 Million - $2.56 Million
177,800 Added 266.17%
244,600 $2.94 Million
Q1 2019

May 10, 2019

SELL
$10.04 - $13.92 $205,819 - $285,360
-20,500 Reduced 23.48%
66,800 $909,000
Q4 2018

Feb 12, 2019

BUY
$8.38 - $13.44 $171,790 - $275,520
20,500 Added 30.69%
87,300 $810,000
Q3 2018

Nov 09, 2018

SELL
$11.6 - $16.54 $19,720 - $28,118
-1,700 Reduced 2.48%
66,800 $0
Q2 2018

Aug 14, 2018

SELL
$13.13 - $17.09 $13,130 - $17,090
-1,000 Reduced 1.44%
68,500 $1.06 Million
Q1 2018

May 03, 2018

SELL
$13.76 - $17.12 $19,264 - $23,968
-1,400 Reduced 1.97%
69,500 $1.01 Million
Q3 2017

Nov 06, 2017

BUY
$11.74 - $15.78 $832,366 - $1.12 Million
70,900
70,900 $893,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.77B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.